Coaching legend Bobby Bowden talks diabetes on ‘Sharing Miracles’
WASHINGTON “Sharing Miracles,” a 30-minute public affairs television program that tells the compelling and inspirational stories of real patients, will share the story of a College Football Hall of Fame coach that is living with Type 2 diabetes.
Bobby Bowden, head coach for Florida State for more than 30 years, shares his story this month of almost being sidelined by the disease.
“Half the people in the United States who have diabetes don’t know it, because they feel fine like I did,” Bowden said. “And if I hadn’t had the physical, then I wouldn’t know now, and I wouldn’t be able to take care of myself the way I do.
Bowden also shares how he keeps his diabetes in check.
“It’s not just my doctor,” he said. “My wife helps me, my kids have helped me. Even my secretaries –– they won’t let me eat what I want! Honestly, I’m lucky; I get help from everybody who knows that I have diabetes.”
“Sharing Miracles” airs on 325 television stations across the country.
Pfizer may buy Ratiopharm
NEW YORK It appears that Pfizer has changed its mind a second time about buying Ratiopharm.
According to published reports, Pfizer has renewed its offer for the German generic drug maker, for $4 billion. That pits the world’s largest drug maker against generic drug makers Teva Pharmaceutical Industries and Actavis.
Pfizer has been on a hunt for opportunities lately, most notably with its acquisition of Wyeth, as it faces patent expirations on such high-selling drugs as the cholesterol medication Lipitor (atorvastatin).
Walgreens completes acquisition of SpecialtyScripts
DEERFIELD, Ill. Walgreens has completed its acquisition of prescription files from Cardinal Health subsidiary SpecialtyScripts, based in Fall River, Mass., Walgreens announced Wednesday.
Founded in 2002, SpecialtyScripts niche is in providing specialty pharmacy services for such chronic illnesses and complex diseases as hepatitis C, psoriasis, rheumatoid arthritis and oral oncology.
Walgreens said the acquisition would allow Walgreens Specialty Pharmacy to scale the operations of its existing locations. Financial terms of the deal were not disclosed.
“We’re excited about our acquisition of SpecialtyScripts and see it as an opportunity to grow our specialty pharmacy business through additional preferred payer agreements,” Walgreens Specialty Pharmacy EVP and Walgreens divisional VP Michael Nameth said in a statement. “It’s a good fit for us because SpecialtyScripts has a similar client base, and we share a commitment to providing patients and customers with quality care and exceptional service.”